Nerissa Kreher - Dec 29, 2021 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Chief Medical Officer
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Stock symbol
TRDA
Transactions as of
Dec 29, 2021
Transactions value $
$10,920
Form type
4
Date filed
12/29/2021, 03:26 PM
Previous filing
Oct 28, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Options Exercise $10.9K +5.2K $2.10* 5.2K Dec 29, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Exercise of in-the-money or at-the-money derivative security $0 -5.2K -3.52% $0.00 143K Dec 29, 2021 Common Stock 5.2K $2.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option vested and became exercisable on December 7, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.